Aplidine: A Paradigm of how to Handle the Activity and Toxicity of a Novel Marine Anticancer Poison

E-ISSN： 1873-4286|13|33|3427-3439

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.13, Iss.33, 2007-11, pp. : 3427-3439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

In vitro characterization of the human biotransformation pathways of aplidine, a novel marine anti-cancer drug

By Brandon Esther Sparidans Rolf Ooijen Ronald Meijerman Irma Lazaro Luis Manzanares Ignacio Beijnen Jos Schellens Jan

Investigational New Drugs, Vol. 25, Iss. 1, 2007-02 ,pp. : 9-19

Springer Publishing Company

Access to resources Recommend Favorite

Pharmacogenetic determinants of anti-cancer drug activity and toxicity

By Danesi R. De Braud F. Fogli S. Di Paolo A. Del Tacca M.

Trends in Pharmacological Sciences, Vol. 22, Iss. 8, 2001-08 ,pp. : 420-426

Elsevier

Access to resources Recommend Favorite

Novel Marine-Derived Anti-Cancer Agents

Current Pharmaceutical Design, Vol. 13, Iss. 33, 2007-01 ,pp. : 3417-3426

Bentham Science Publishers

Access to resources Recommend Favorite

Anticancer Platinum (IV) Prodrugs with Novel Modes of Activity

Current Topics in Medicinal Chemistry, Vol. 11, Iss. 21, 2011-11 ,pp. : 2602-2612

Bentham Science Publishers

Access to resources Recommend Favorite

Novel Colchicine Derivatives and their Anti-cancer Activity

Current Topics in Medicinal Chemistry, Vol. 17, Iss. 22, 2017-07 ,pp. : 2538-2558

Bentham Science Publishers

Access to resources Recommend Favorite